These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29384793)

  • 1. Letter to the Editor on the "European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery" by Querleu et al, Int J Gynecol Cancer 2016;26: 1354-1363.
    Salehi S; Hjerpe E; Falconer H
    Int J Gynecol Cancer; 2018 Mar; 28(3):426-427. PubMed ID: 29384793
    [No Abstract]   [Full Text] [Related]  

  • 2. The limits of aggressive surgical cytoreduction.
    Levine DA
    Gynecol Oncol; 2018 Aug; 150(2):205-206. PubMed ID: 30025830
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update.
    Fotopoulou C; Concin N; Planchamp F; Morice P; Vergote I; du Bois A; Querleu D
    Int J Gynecol Cancer; 2020 Apr; 30(4):436-440. PubMed ID: 32086362
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.
    Greggi S; Falcone F; Carputo R; Raspagliesi F; Scaffa C; Laurelli G; Giorda G; Di Vagno G; Petruzzelli F; Cormio G; Marinaccio M; Pignata S
    Gynecol Oncol; 2016 Mar; 140(3):425-9. PubMed ID: 26825616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.
    Querleu D; Planchamp F; Chiva L; Fotopoulou C; Barton D; Cibula D; Aletti G; Carinelli S; Creutzberg C; Davidson B; Harter P; Lundvall L; Marth C; Morice P; Rafii A; Ray-Coquard I; Rockall A; Sessa C; van der Zee A; Vergote I; duBois A
    Int J Gynecol Cancer; 2017 Sep; 27(7):1534-1542. PubMed ID: 30814245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.
    Gómez-Hidalgo NR; Martinez-Cannon BA; Nick AM; Lu KH; Sood AK; Coleman RL; Ramirez PT
    Gynecol Oncol; 2015 Jun; 137(3):553-8. PubMed ID: 25827290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality control of the surgical management of advanced ovarian carcinoma].
    Pomel C; Lecuru F; Rouzier R; Dauplat J; Ferron G
    J Gynecol Obstet Biol Reprod (Paris); 2012 Feb; 41(1):3-5. PubMed ID: 22192233
    [No Abstract]   [Full Text] [Related]  

  • 8. Upping the ante in assessing the feasibility of surgical cytoreduction for advanced ovarian cancer: a modified laparoscopic Predictive Index score.
    Ramirez PT
    Gynecol Oncol; 2015 Oct; 139(1):1-2. PubMed ID: 26411361
    [No Abstract]   [Full Text] [Related]  

  • 9. When and Who Should Perform Epithelial Ovarian Cancer Surgery?
    Escayola C; Torrent JJ; Ferron G; Quenet F; Querleu D
    Int J Gynecol Cancer; 2018 Mar; 28(3):594-599. PubMed ID: 29303937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
    Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
    J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.
    Querleu D; Planchamp F; Chiva L; Fotopoulou C; Barton D; Cibula D; Aletti G; Carinelli S; Creutzberg C; Davidson B; Harter P; Lundvall L; Marth C; Morice P; Rafii A; Ray-Coquard I; Rockall A; Sessa C; van der Zee A; Vergote I; du Bois A
    Int J Gynecol Cancer; 2016 Sep; 26(7):1354-63. PubMed ID: 27648648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery for ovarian cancer: quality assessment.
    Brand AH; DiSilvestro PA; Sehouli J; Berek JS
    Ann Oncol; 2017 Nov; 28(suppl_8):viii25-viii29. PubMed ID: 29232471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
    Eisenkop SM; Spirtos NM
    Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meigs to modern times: The evolution of debulking surgery in advanced ovarian cancer.
    Schorge JO; Bregar AJ; Durfee J; Berkowitz RS
    Gynecol Oncol; 2018 Jun; 149(3):447-454. PubMed ID: 29525276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of ovarian cancer surgery quality indicators using a modified Delphi approach.
    Gagliardi AR; Fung MF; Langer B; Stern H; Brown AD
    Gynecol Oncol; 2005 May; 97(2):446-56. PubMed ID: 15863144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "definitive" trial of surgical cytoreduction in advanced-stage ovarian cancer.
    Naik R; Spirtos N; Pomel C; Bristow R; Chi D; Vergote I; Donovan J
    Int J Gynecol Cancer; 2013 May; 23(4):588-91. PubMed ID: 23611959
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen.
    Bristow RE
    Gynecol Oncol; 2009 Jan; 112(1):1-3. PubMed ID: 19100914
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.
    Harter P; Muallem ZM; Buhrmann C; Lorenz D; Kaub C; Hils R; Kommoss S; Heitz F; Traut A; du Bois A
    Gynecol Oncol; 2011 Jun; 121(3):615-9. PubMed ID: 21414656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
    Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
    Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer.
    Saitou M; Iida Y; Komazaki H; Narui C; Matsuno K; Kawabata A; Ueda K; Tanabe H; Takakura S; Isonishi S; Sasaki H; Okamoto A
    Arch Gynecol Obstet; 2015 Mar; 291(3):641-6. PubMed ID: 25182215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.